Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mutlu Hayran

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Tumori|March 15, 2008
Factors affecting survival in breast cancer patients following bone metastasisOzlem Yavas, Mutlu Hayran, Yavuz Ozisik
Journal of Radiation Research|August 24, 2012
Mean esophageal radiation dose is predictive of the grade of acute esophagitis in lung cancer patients treated with concurrent radiotherapy and chemotherapyAytul Ozgen, Mutlu Hayran, Fatih Kahraman
Journal of Back and Musculoskeletal Rehabilitation|June 12, 2012
Effects of different segmental spinal stabilization exercise protocols on postural stability in asymptomatic subjects: randomized controlled trialDerya Ozer Kaya, Nevin Ergun, Mutlu Hayran
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 26, 2008
Immunohistochemical expression of multidrug resistance proteins in mature T/NK-cell lymphomasArzu Saglam, Mutlu Hayran, Aysegul H Uner
Pediatric Hematology and Oncology|February 12, 2009
Undulant course of AFP: a sign of tumor activation or not?G Burca Aydin, Mutlu Hayran, Münevver Büyükpamukçu
American Journal of Clinical Dermatology|October 15, 2009
Patient characteristics in Behçet disease: a retrospective analysis of 213 Turkish patients during 2001-4Nuran Alli, Gunes Gur, Basak Yalcin, et al.
BMC Cancer|February 17, 2019
Reproductive cancer risk factors among relatives of cancer patients in a tertiary oncology centerNooria Atta, Saadettin Kilickap, Deniz Yuce, et al.
Scandinavian Journal of Infectious Diseases|June 27, 2006
Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospitalGokhan Metan, Mutlu Hayran, Gulsen Hascelik, et al.
Leukemia & Lymphoma|March 6, 2009
Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysisSercan Aksoy, Omer Dizdar, Mutlu Hayran, et al.
American Journal of Perinatology|October 7, 2014
A clinical scoring system to predict the development of bronchopulmonary dysplasiaTugba Gursoy, Mutlu Hayran, Hatice Derin, et al.
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Tumori|March 15, 2008
Factors affecting survival in breast cancer patients following bone metastasisOzlem Yavas, Mutlu Hayran, Yavuz Ozisik
Journal of Radiation Research|August 24, 2012
Mean esophageal radiation dose is predictive of the grade of acute esophagitis in lung cancer patients treated with concurrent radiotherapy and chemotherapyAytul Ozgen, Mutlu Hayran, Fatih Kahraman
Journal of Back and Musculoskeletal Rehabilitation|June 12, 2012
Effects of different segmental spinal stabilization exercise protocols on postural stability in asymptomatic subjects: randomized controlled trialDerya Ozer Kaya, Nevin Ergun, Mutlu Hayran
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 26, 2008
Immunohistochemical expression of multidrug resistance proteins in mature T/NK-cell lymphomasArzu Saglam, Mutlu Hayran, Aysegul H Uner
Pediatric Hematology and Oncology|February 12, 2009
Undulant course of AFP: a sign of tumor activation or not?G Burca Aydin, Mutlu Hayran, Münevver Büyükpamukçu
American Journal of Clinical Dermatology|October 15, 2009
Patient characteristics in Behçet disease: a retrospective analysis of 213 Turkish patients during 2001-4Nuran Alli, Gunes Gur, Basak Yalcin, et al.
BMC Cancer|February 17, 2019
Reproductive cancer risk factors among relatives of cancer patients in a tertiary oncology centerNooria Atta, Saadettin Kilickap, Deniz Yuce, et al.
Scandinavian Journal of Infectious Diseases|June 27, 2006
Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospitalGokhan Metan, Mutlu Hayran, Gulsen Hascelik, et al.
Leukemia & Lymphoma|March 6, 2009
Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysisSercan Aksoy, Omer Dizdar, Mutlu Hayran, et al.
American Journal of Perinatology|October 7, 2014
A clinical scoring system to predict the development of bronchopulmonary dysplasiaTugba Gursoy, Mutlu Hayran, Hatice Derin, et al.
Pageof 14